Serum uric acid and triglycerides in clear cell renal cell carcinoma: A restrospective cross-sectional study

Author:

Yue Dong12ORCID,Tian Jun1

Affiliation:

1. Department of Organ Transplantation, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Lixia District, Jinan, Shandong Province, China

2. Department of Urology, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, China.

Abstract

The available evidence on the relationship between serum uric acid and triglycerides in clear cell renal cell carcinoma (ccRCC) is limited. The objective of this study is to investigate whether there is an independent association between serum uric acid and triglycerides in ccRCC, while adjusting for other variables. This cross-sectional study involved 1018 participants with ccRCC, who were admitted to a hospital in China from December 1st, 2013 to January 1st, 2023. The main independent variable investigated was serum uric acid, which was measured at baseline. The dependent variable was triglycerides. Covariates considered in this study included age, sex, body mass index, smoking status, hypertension, diabetes, coronary disease, High-density lipoprotein cholesterol, Low-density lipoprotein cholesterol, Total cholesterol, Blood urea nitrogen, and Creatinine. The study included 1018 participants with an average age of 56.92 ± 10.88 years old, and approximately 68% of them were male. The fully-adjusted linear regression analysis indicated a positive association between serum uric acid levels (100μmol/L) and triglyceride levels (mmol/L) after adjusting for confounding factors (β = 0.13, 95% CI [0.07, 0.18]). Furthermore, a smooth curve was constructed between serum uric acid and triglycerides based on the fully-adjusted model. In patients with ccRCC, there was a positive association between serum uric acid and triglycerides.

Funder

no

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference30 articles.

1. Current status of predictive biomarker development in metastatic renal cell carcinoma.;Fotia;Curr Oncol Rep,2023

2. Cancer statistics, 2023.;Siegel;CA Cancer J Clin,2023

3. Epidemiology of renal cell carcinoma.;Capitanio;Eur Urol,2019

4. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment.;Bahadoram;G Ital Nefrol,2022

5. Predicting oncologic outcomes in renal cell carcinoma after surgery.;Leibovich;Eur Urol,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3